Title:
膣真菌感染症の治療のためのグルコノデルタ−ラクトン
Document Type and Number:
Japanese Patent JP6967785
Kind Code:
B2
Abstract:
The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone, wherein the glucono δ-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
Inventors:
Ellervic, Wolf
Storner, Olof
Strebuns, Helena
Manner, Sophie
Storner, Olof
Strebuns, Helena
Manner, Sophie
Application Number:
JP2018548699A
Publication Date:
November 17, 2021
Filing Date:
April 06, 2017
Export Citation:
Assignee:
Jedia Biotech AB
International Classes:
A61K31/366; A61K9/08; A61K31/4196; A61K31/496; A61P15/02; A61P31/10; F27B3/12; F27B14/00; F27B14/06; F27B14/10; F27D1/16; H05B6/24; F27B14/08
Other References:
Jpn. J. Food Microbiol.,2009年,Vol.26, No.2,p.81-85
Med. Mycol. J.,2013年,Vol.54,p.11-18
Med. Mycol. J.,2013年,Vol.54,p.11-18
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Akiyo Iwahori
Kaoru Takahashi
Nao Oda
Akiyo Iwahori
Kaoru Takahashi